Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.11%40.16B | -2.83%9.82B | -3.59%9.88B | 0.78%40.2B | -4.68%9.13B | -3.47%10.72B | 6.62%10.11B | 5.31%10.25B | 5.85%39.89B | 8.94%9.58B |
| Cost of revenue | 0.46%31.76B | -1.98%7.77B | -2.23%7.85B | -0.87%31.61B | -4.39%7.16B | -5.04%8.49B | 5.07%7.93B | 1.52%8.03B | 4.65%31.89B | 4.70%7.49B |
| Gross profit | -2.21%8.4B | -5.88%2.05B | -8.57%2.03B | 7.37%8.59B | -5.69%1.97B | 3.10%2.23B | 12.62%2.18B | 21.89%2.22B | 10.94%8B | 27.33%2.09B |
| Operating expense | 3.19%7.02B | 1.76%1.73B | 0.52%1.74B | 2.60%6.8B | 2.52%1.67B | 0.41%1.69B | 2.77%1.7B | 4.71%1.73B | 2.08%6.63B | 3.63%1.63B |
| Selling and administrative expenses | 3.19%7.02B | ---- | ---- | 2.60%6.8B | ---- | ---- | ---- | ---- | 2.08%6.63B | ---- |
| -Selling and marketing expense | 10.99%1.97B | ---- | ---- | -1.88%1.78B | ---- | ---- | ---- | ---- | -2.53%1.81B | ---- |
| -General and administrative expense | 0.44%5.05B | ---- | ---- | 4.28%5.02B | ---- | ---- | ---- | ---- | 3.93%4.82B | ---- |
| Operating profit | -22.69%1.39B | -33.33%316M | -41.20%284M | 30.38%1.79B | -34.41%305M | 12.71%532M | 71.74%474M | 196.32%483M | 90.58%1.38B | 536.99%465M |
| Net non-operating interest income (expenses) | -1.90%-215M | 1.75%-56M | 3.70%-52M | 9.83%-211M | 16.67%-45M | 9.84%-55M | 6.56%-57M | 6.90%-54M | 0.43%-234M | 11.48%-54M |
| Non-operating interest income | -37.50%5M | ---- | ---- | 300.00%8M | ---- | ---- | ---- | ---- | --2M | ---- |
| Non-operating interest expense | 0.46%220M | -1.75%56M | -3.70%52M | -7.20%219M | -5.36%53M | -9.84%55M | -6.56%57M | -6.90%54M | 0.43%236M | -8.20%56M |
| Net investment income | -28.82%242M | -190.14%-64M | 4.26%147M | 47.83%340M | 521.43%59M | 146.43%69M | 31.48%71M | -12.96%141M | 67.88%230M | -153.85%-14M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 223.33%37M | 1,383.33%77M | 93.33%-3M | 85.00%-30M | 88.89%-3M | 380.00%24M | 96.49%-6M | -542.86%-45M | -1,150.00%-200M | -285.71%-27M |
| Less:Other special charges | -323.33%-67M | -1,383.33%-77M | -93.33%3M | -85.00%30M | -88.89%3M | -380.00%-24M | -96.49%6M | 542.86%45M | 1,150.00%200M | 285.71%27M |
| Less:Write off | --30M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 218.75%19M | 78.57%-3M | 300.00%4M | 50.00%-16M | 0.00%-6M | 500.00%6M | 46.15%-14M | -100.00%-2M | -500.00%-32M | -700.00%-6M |
| Income before tax | -21.87%1.47B | -42.86%268M | -27.01%381M | 64.82%1.88B | -14.29%312M | 29.44%576M | 551.39%469M | 101.54%522M | 84.47%1.14B | 1,003.03%364M |
| Income tax | -34.08%147M | -24.73%70M | -10.34%78M | 16.75%223M | -584.62%-63M | 20.45%106M | 126.83%93M | 77.55%87M | 32.64%191M | 44.44%13M |
| Net income | -20.18%1.32B | -47.07%199M | -30.41%302M | 74.39%1.66B | 6.53%375M | 32.02%470M | 1,075.00%376M | 107.66%434M | 100.21%949M | 1,308.00%352M |
| Net income continuous operations | -20.23%1.32B | -47.34%198M | -30.34%303M | 74.50%1.66B | 6.84%375M | 31.65%470M | 1,112.90%376M | 107.14%435M | 100.21%949M | 1,362.50%351M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -20.18%1.32B | -47.07%199M | -30.41%302M | 74.39%1.66B | 6.53%375M | 32.02%470M | 1,075.00%376M | 107.66%434M | 100.21%949M | 1,308.00%352M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -20.18%1.32B | -47.07%199M | -30.41%302M | 74.39%1.66B | 6.53%375M | 32.02%470M | 1,075.00%376M | 107.66%434M | 100.21%949M | 1,308.00%352M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.84%324.85 | -47.31%48.45 | -30.74%73.95 | 73.55%405.25 | 6.00%91.65 | 31.07%114.87 | 1,089.65%91.96 | 106.64%106.77 | 91.50%233.5 | 1,727.91%86.46 |
| Diluted earnings per share | -19.84%324.85 | -47.31%48.45 | -30.74%73.95 | 73.55%405.25 | 6.07%91.65 | 31.44%114.87 | 1,089.65%91.96 | 106.64%106.77 | 91.50%233.5 | 1,726.82%86.4084 |
| Dividend per share | 12.50%90 | 0 | 0 | 100.00%80 | 100.00%80 | 0 | 0 | 0 | 40 | 40 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |